Aug 14, 2026 04:00PM
Jul 31, 2026 04:00PM
Jun 12, 2026 01:00PM
Jun 12, 2026 01:00PM
Jun 11, 2026 05:00PM
May 14, 2026 05:00PM
May 13, 2026 05:00PM Management team’s 2025 market-based Options have vested
May 6, 2026 05:00PM
Mar 12, 2026 05:00PM
Mar 10, 2026 09:00AM
Feb 25, 2026 09:30AM
Jan 15, 2026 09:00AM
Dec 5, 2025 10:00AM
Nov 14, 2025 04:30PM Precipio Announces its Q3-2025 Financial Results
Nov 4, 2025 05:00PM
Sep 2, 2025 10:01AM
Sep 2, 2025 10:00AM
Aug 13, 2025 05:00PM
Jul 31, 2025 04:30PM
Jul 11, 2025 04:30PM
Jul 11, 2025 04:30PM Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
Jun 16, 2025 12:00PM
May 14, 2025 05:00PM
May 1, 2025 05:00PM
Mar 17, 2025 05:00PM
Feb 25, 2025 09:30AM
Jan 16, 2025 05:00PM
Nov 6, 2024 05:00PM Precipio Announces Q3-2024 Shareholder Update Call
Oct 8, 2024 10:00AM
Sep 6, 2024 04:00PM
Aug 15, 2024 05:00PM
Jul 25, 2024 09:00AM
Jul 17, 2024 09:00AM
Jun 13, 2024 04:00PM
Jun 12, 2024 04:00PM Precipio (PRPO) requesting Shareholders/Brokers vote today to avoid adjournment and rescheduling of AGM
Jun 12, 2024 04:00PM
Jun 12, 2024 09:04AM
Jun 12, 2024 09:00AM
May 6, 2024 05:00PM
Mar 25, 2024 05:00PM
Feb 13, 2024 10:00AM
Feb 6, 2024 10:01AM Precipio (PRPO) and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer
Feb 6, 2024 10:00AM
Jan 23, 2024 10:00AM
Jan 17, 2024 10:30AM
Jan 2, 2024 09:02AM
Jan 2, 2024 09:00AM
Nov 16, 2023 05:00PM
Oct 18, 2023 09:00AM Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022
Oct 3, 2023 10:00AM

1,222,760 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All